最新モデル from Survival Overall 24-Month KEYNOTE-021 G Cohort 検査キットの詳細情報
24-Month Overall Survival from KEYNOTE-021 Cohort G。Evaluation of Candidate Theranostics for 227Th/89Zr Paired。Biomarker-Directed Phase II Platform Study in Patients With。Human IL-4 R alpha/IL-13 R alpha 1 (Luc) HEK293 Reporter。